Cargando…
A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report
Inflammatory myofibroblastic tumor (IMT) is a rare sarcoma with unique molecular characteristics. It also has typical fasciitis-like, dense spindle cells and hypocellular fibrous histologic patterns and can occur at any age. The etiology of IMT is unknown and a complete treatment and monitoring plan f...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798890/ https://www.ncbi.nlm.nih.gov/pubmed/35116312 http://dx.doi.org/10.21037/tcr-21-899 |
_version_ | 1784641927981826048 |
---|---|
author | Zhu, Tianle Gao, Pan Gao, Jingjing Liu, Xi Zhang, Xiansheng |
author_facet | Zhu, Tianle Gao, Pan Gao, Jingjing Liu, Xi Zhang, Xiansheng |
author_sort | Zhu, Tianle |
collection | PubMed |
description | Inflammatory myofibroblastic tumor (IMT) is a rare sarcoma with unique molecular characteristics. It also has typical fasciitis-like, dense spindle cells and hypocellular fibrous histologic patterns and can occur at any age. The etiology of IMT is unknown and a complete treatment and monitoring plan for IMT have not been developed. We have found a rare case about a huge recurrent IMT implicating renal and ureter. The patient was accompanied by a history of a lesion sized 15.5 cm × 11.5 cm × 10.5 cm as a retroperitoneal IMT, and the first tumor resection was performed 12 months ago. The patient, who suffered from tumor recurrence within 1 year and whose recurrent tumor also invaded into the renal parenchymal was given a retroperitoneal neoplasm resection plus right nephrectomy. In order to clarify the pathological features, the histological specimens of recurrent retroperitoneal IMT were examined as well as primary retroperitoneal IMT, and immunohistochemical (IHC) stains showed that the spindle cells were positive for vimentin and negative for anaplastic lymphoma kinase (ALK). At 24 months follow-up, the patient recovered well and there was no evidence of tumor recurrence. This case report is conducive to understanding this rare tumor. When conditions permit, complete surgical resection is the recommended treatment for primary and recurrent IMT. |
format | Online Article Text |
id | pubmed-8798890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87988902022-02-02 A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report Zhu, Tianle Gao, Pan Gao, Jingjing Liu, Xi Zhang, Xiansheng Transl Cancer Res Case Report Inflammatory myofibroblastic tumor (IMT) is a rare sarcoma with unique molecular characteristics. It also has typical fasciitis-like, dense spindle cells and hypocellular fibrous histologic patterns and can occur at any age. The etiology of IMT is unknown and a complete treatment and monitoring plan for IMT have not been developed. We have found a rare case about a huge recurrent IMT implicating renal and ureter. The patient was accompanied by a history of a lesion sized 15.5 cm × 11.5 cm × 10.5 cm as a retroperitoneal IMT, and the first tumor resection was performed 12 months ago. The patient, who suffered from tumor recurrence within 1 year and whose recurrent tumor also invaded into the renal parenchymal was given a retroperitoneal neoplasm resection plus right nephrectomy. In order to clarify the pathological features, the histological specimens of recurrent retroperitoneal IMT were examined as well as primary retroperitoneal IMT, and immunohistochemical (IHC) stains showed that the spindle cells were positive for vimentin and negative for anaplastic lymphoma kinase (ALK). At 24 months follow-up, the patient recovered well and there was no evidence of tumor recurrence. This case report is conducive to understanding this rare tumor. When conditions permit, complete surgical resection is the recommended treatment for primary and recurrent IMT. AME Publishing Company 2021-10 /pmc/articles/PMC8798890/ /pubmed/35116312 http://dx.doi.org/10.21037/tcr-21-899 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Case Report Zhu, Tianle Gao, Pan Gao, Jingjing Liu, Xi Zhang, Xiansheng A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report |
title | A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report |
title_full | A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report |
title_fullStr | A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report |
title_full_unstemmed | A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report |
title_short | A huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report |
title_sort | huge recurrent retroperitoneal inflammatory myofibroblastic tumor implicating renal and ureter: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798890/ https://www.ncbi.nlm.nih.gov/pubmed/35116312 http://dx.doi.org/10.21037/tcr-21-899 |
work_keys_str_mv | AT zhutianle ahugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT gaopan ahugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT gaojingjing ahugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT liuxi ahugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT zhangxiansheng ahugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT zhutianle hugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT gaopan hugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT gaojingjing hugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT liuxi hugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport AT zhangxiansheng hugerecurrentretroperitonealinflammatorymyofibroblastictumorimplicatingrenalandureteracasereport |